LEXICON PHARMACEUTICALS INC
NASDAQ: LXRX (Lexicon Pharmaceuticals, Inc.)
Kemas kini terakhir: 1 jam lalu2.02
-0.13 (-6.05%)
| Penutupan Terdahulu | 2.15 |
| Jumlah Dagangan | 2,937,951 |
| Harga / Jualan (P/S) | 21.04 |
| Harga / Buku (P/B) | 5.69 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -2,034.79% |
| EPS Cair (TTM) | -0.500 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 11.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 86.37% |
| Nisbah Semasa (MRQ) | 2.22 |
| Aliran Tunai Operasi (OCF TTM) | -167.43 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -93.95 M |
| Pulangan Atas Aset (ROA TTM) | -28.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -86.09% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Lexicon Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.33 |
|
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.17% |
| % Dimiliki oleh Institusi | 74.93% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Artal Group S.A. | 30 Jun 2026 | 175,156,062 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |